Navigation Links
Cambrex Reports First Quarter 2009 Results
Date:5/5/2009

the first quarter 2008, respectively. The decrease in capital spending is largely due to higher first quarter 2008 spending on two large capital projects for which the majority of spending has since been completed.

Guidance

The Company continues to expect that sales, net of the impact of foreign currency, will increase between 2% and 6% in 2009 compared to 2008, and that Adjusted EBITDA will be between $42 and $49 million. Adjusted EBITDA for guidance purposes excludes the impact of any potential M&A, restructuring, or strategic alternatives expenses. Considering the current macro-economic environment, the Company continues to believe that there is a high level of uncertainty regarding sales and profit forecasts for 2009, especially as it pertains to the Company's custom development sales to support our customers' clinical trials.

For 2009, capital expenditures are expected to be approximately $13 to $16 million and depreciation is expected to be $20 to $22 million. The Company currently expects restructuring and strategic alternatives expenses for 2009 to be minimal.

The financial information contained in this press release is unaudited, subject to revision and should not be considered final until the first quarter 2009 Form 10-Q is filed with the SEC.

Conference Call and Webcast

The Conference Call to discuss first quarter 2009 results will begin at 8:30 a.m. Eastern Time on Wednesday, May 6, 2009 and last approximately 45 minutes. Those wishing to participate should call 1-888-634-4003 for domestic and +1-706-634-6653 for international. Please use the pass code 97216999 and call approximately 10 minutes prior to start time. A webcast is available from the Investors section on the Cambrex website located at www.cambrex.com and can be accessed for 30 days following the conference call.
'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cambrex Receives Notice Regarding NYSE Listing
2. Cambrex Reports Third Quarter 2008 Results
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
5. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
6. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
8. United Therapeutics Reports First Quarter 2009 Financial Results
9. Osteotech Reports First Quarter 2009 Financial Results
10. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
11. Idenix Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... have made a breakthrough in understanding the effect on ... The discovery could lead to more accurate forecasting of ... , Crozier is an associate professor in ASU,s School ... of Liberal Arts and Sciences and the Ira A. ...
... SGXP ) today announced its financial results for the ... months ended June 30, 2008, the,Company posted revenues of $4.3 ... months ended June 30, 2008, revenues were $21.3 million and ... month period includes $10.8,million of revenue earned in the first ...
... Verenium Corporation,(Nasdaq: VRNM ), a leading ... the development of high-performance specialty enzymes, announced,today that ... present at,the upcoming Canaccord Adams 28th Annual Global ... 10:30 a.m. ET on Thursday, August 14,and will ...
Cached Biology Technology:Forward step in forecasting global warming 2Forward step in forecasting global warming 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 4SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 5SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 6SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 7SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 8SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 9Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference 2Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference 3
(Date:4/15/2014)... fixed carbon and energy for nearly all life on ... mysterious. For example, little is known about how it ... More fundamentally, we do not know the full list ... photosynthesis in any organism. , , A type of ... a leading subject for photosynthesis research. Despite its importance ...
(Date:4/15/2014)... Mass. Diana Lados, associate professor of ... and founding director of the university,s Integrative ... major career achievement awards from leading engineering ... Detroit, SAE International, a global association of ... experts in the automotive, aerospace, and commercial ...
(Date:4/15/2014)... social behavior has developed over the course of evolution, ... gained new insights from the study of earwigs. "Young ... siblings share what is available amongst themselves, especially when ... the Evolutionary Biology section of the Institute of Zoology ... of biologists from Mainz University and the University of ...
Breaking Biology News(10 mins):WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 2WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 3WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 4WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 5Sibling cooperation in earwig families gives clues to early evolution of social behavior 2
... world record for the most densely populated space and now ... the most species rich area on earth. The team,s findings, ... the record is contested between South America,s tropical rainforests and ... species in one space and the questions it raises have ...
... Professor Russell Chesney, M.D. believes he knows what was ailing ... Carol." Based on detailed descriptions of both the symptoms ... that Tiny Tim suffered from a combination of rickets and ... 5 edition of Archives of Pediatrics and Adolescent Medicine ...
... found a way to create temporary holes in the membranes ... will be published in JoVE, the Journal of Visualized ... idea for this method when we wanted to be able ... forces on cells," said paper-author Dr. Delphine Dean. She ...
Cached Biology News:European grasslands challenge rainforests as the most species-rich spaces on Earth 2Researchers print live cells with a standard inkjet printer 2
... exchange media are rigid macroporous hydrophilic media. ... rates at moderate pressures, while the macroporous ... the hydrophilic matrix reduces nonspecific binding. Macro-Prep ... anion exchanger with very high flow rates ...
... Spring offers a large collection of ... fetal tissuea, cell lines, and mouse ... in pHD9 vector. The size of ... be from 200bp to 1000bp by ...
... Corticosterone kit is a competitive enzymeimmunoassay (EIA) ... mouse or rat serum or plasma. Corticosterone ... in rats and mice, and in most ... reptiles. Most mammals produce both corticosterone and ...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Biology Products: